OP-106 Horizon - Melflufen therapy for RRMM patients refractory to Daratumumab and/or Pomalidomide; updated results and first report on ITS

Autores: Richardson, P. ; Ocio, E.; Oriol, A. ; Larocca, A.; Rodríguez Otero, Paula; Moreb, J.; Blade, J.; Hassoun, H.; Cavo, M.; Alegre, A.; Mazumder, A. ; Maisel, C.; Paner, A. ; Gabrail, N.; Zonder, J. A.; Chauhan, D.; Harmenberg, J.; Thuresson, S.; Zubairand, H.; Mateos, M. V.